University of Santa Monica

Recent papers from University of Santa Monica

1. Jackhammer Esophagus Presenting as Chest Discomfort and Dyspnea in a Patient With Undifferentiated Inflammatory Arthritis and a Positive Scl-70 Antibody TestCureus · 2026
2. Lessons from Cohort Studies of Targetable Metabolic Deficiencies in Lung CancerClinical Cancer Research · 2026
3. A Phase 1 Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients With Advanced Gastrointestinal CancersCancer Research Communications · 2026
4. From Digital Conditions to Business Value: A TOE-TAM Process Model of Business Digitalization and SME PerformanceInternational Journal of Academic Research in Business and Social Sciences · 2026
5. Precision Medicine Begins with Precision Language: “Hypoxic Burden” Should Be “Hypoxemic Burden”American Journal of Respiratory and Critical Care Medicine · 2026
6. Effectiveness and Safety of RHA4 Versus Comparator Product for Midface Volume Deficiency: A Randomized, Prospective, Multicenter Clinical StudyJournal of Cosmetic Dermatology · 2026
7. Utilizing machine learning to identify multimodal signatures for patients who would benefit from the addition of tremelimumab to durvalumab and chemotherapy (TRIDENT)Clinical Cancer Research · 2026
8. Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biologynpj Precision Oncology · 2026
9. A phase I/IIa, image-guided, alpha-particle therapy study of [ ²⁰³ Pb]Pb-PSV359 and [ ²¹² Pb]Pb-PSV359 in patients with solid tumors that are known to be fibroblast activation protein (FAP)–positive.Journal of Clinical Oncology · 2026
10. Osteoporosis and adult spinal deformity—a review for spinal surgeons by the SRS adult spinal deformity task force on senescenceSpine Deformity · 2026
11. The United States Leads the Globe in Venture Capital Funding for Orthopaedic SurgeryArthroscopy Sports Medicine and Rehabilitation · 2026
12. Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancerESMO Gastrointestinal Oncology · 2026
13. Dental Surgeries in Hospitals and Surgery Centers for Children With Developmental DisabilitiesHospital Pediatrics · 2026
14. First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 StudyClinical Cancer Research · 2026
15. Abstract 4641: Highly soluble prodrug boronophenylalanine (L-BPA) dipeptide, exhibits notable tumor suppression whilst inducing cancer vaccine effect post neutron irradiation treatmentCancer Research · 2026
16. Abstract 4243: Mutational-signature adjusted models reveal HLA-mediated depletion of antigenic mutations in non-small cell lung cancer (NSCLC)Cancer Research · 2026
17. Abstract 1605: Motif neoepitopes demonstrate immunogenic signal in CCL21-gene modified dendritic cell vaccination trial (NCT03546361)Cancer Research · 2026
18. Abstract 6740: Selective immune activation of antigen activated T cells with STK-012, an a/b IL-2 receptor biased partial agonist, with pembrolizumab and chemotherapy in 1L PD-L1 negative non-squamous NSCLCCancer Research · 2026
19. 1O Efficacy and safety of setidegrasib in patients (pts) with advanced NSCLC with KRAS G12D mutationESMO Open · 2026
20. Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsCancer Discovery · 2026